title: New treatment for patients with advanced ovarian cancer receives accelerated approval.
authors.forename: Carrie
authors.initials: C
authors.lastname: Printz
mesh_terms: D019313:BRCA1 Protein / Q000235:genetics; D017277:Drug Approval; D005260:Female; D006801:Humans; D007211:Indoles / Q000009:adverse effects / Q000627:therapeutic use*; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000453:epidemiology / Q000473:pathology; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D019313:BRCA1 Protein; D007211:Indoles; C531549:rucaparib